AU4380572A - Pharmaceutical powder composition for inhalation - Google Patents

Pharmaceutical powder composition for inhalation

Info

Publication number
AU4380572A
AU4380572A AU43805/72A AU4380572A AU4380572A AU 4380572 A AU4380572 A AU 4380572A AU 43805/72 A AU43805/72 A AU 43805/72A AU 4380572 A AU4380572 A AU 4380572A AU 4380572 A AU4380572 A AU 4380572A
Authority
AU
Australia
Prior art keywords
inhalation
powder composition
pharmaceutical powder
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU43805/72A
Other versions
AU462722B2 (en
Inventor
RAYMOND GUNNING and PHILIP SALTON HARTLEY STEPHEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of AU4380572A publication Critical patent/AU4380572A/en
Application granted granted Critical
Publication of AU462722B2 publication Critical patent/AU462722B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43805/72A 1971-06-22 1972-06-22 Pharmaceutical powder composition for inhalation Expired AU462722B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2920771A GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation
GBGB29207/71 1971-06-22

Publications (2)

Publication Number Publication Date
AU4380572A true AU4380572A (en) 1974-01-03
AU462722B2 AU462722B2 (en) 1975-07-03

Family

ID=10287853

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43805/72A Expired AU462722B2 (en) 1971-06-22 1972-06-22 Pharmaceutical powder composition for inhalation

Country Status (9)

Country Link
JP (1) JPS5046820A (en)
AU (1) AU462722B2 (en)
CA (1) CA970685A (en)
DE (1) DE2229981C3 (en)
DK (1) DK134970B (en)
FR (1) FR2143163B2 (en)
GB (1) GB1381872A (en)
NL (1) NL176743C (en)
ZA (1) ZA723999B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2332663C2 (en) * 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Use of corticosteroid active ingredients for inhalation therapy
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
JPS6034925B2 (en) * 1979-07-31 1985-08-12 帝人株式会社 Long-acting nasal preparation and its manufacturing method
BE891013A (en) * 1980-11-05 1982-05-05 Fisons Ltd PHARMACEUTICAL COMPOSITIONS
IT1220979B (en) * 1981-06-04 1990-06-21 Lofarma Farma Lab CAPSULES CONTAINING AN ALLERGEN AND PROCEDURE FOR THEIR PREPARATION
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
DE3688617T2 (en) * 1986-11-03 1993-11-18 Allen W Jacobs Process for admixing a solid particulate component in aerosol preparations for inhalation of nicotine.
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (en) * 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ITMI991582A1 (en) 1999-07-16 2001-01-16 Chiesi Farma Spa DUST CONSTITUTED FROM PARTICLES HAVING THE PERFECTLY SMOOTH SURFACE FOR USE AS VEHICLES FOR THE PREPARATION OF INALA MIXTURES
AU7685200A (en) 1999-10-12 2001-04-23 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
PE20011227A1 (en) 2000-04-17 2002-01-07 Chiesi Farma Spa PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
WO2002000197A1 (en) 2000-06-27 2002-01-03 Vectura Limited Method of making particles for use in a pharmaceutical composition
PT1920763E (en) 2000-11-30 2014-06-25 Vectura Ltd Pharmaceutical compositions for inhalation
EP1337239B2 (en) 2000-11-30 2015-11-25 Vectura Limited Particles for use in a pharmaceutical composition
AR046225A1 (en) 2003-11-04 2005-11-30 Glaxo Group Ltd COMPOSITE OF 8-AZONIABICICLO (3.2.1) OCTOBER, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES MEDIATED BY MUSCARINIC ACETILCOLINE RECEPTORS THAT UNDERSTAND IT AND USE OF THE COMPOUND TO PREPARE SUCH COMPOSITION
UY28871A1 (en) 2004-04-27 2005-11-30 Glaxo Group Ltd ANTAGONISTS OF THE MUSCARINIC ACETILCOLINE RECEIVER
KR20070119631A (en) 2005-02-10 2007-12-20 글락소 그룹 리미티드 Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
DK2400950T3 (en) 2009-02-26 2019-07-29 Glaxo Group Ltd PHARMACEUTICAL FORMULA comprising 4 - {(1 R) -2 - [(6- {2 - [(2,6-DICHLORBENZYL) OXY] ETHOXY} HEXYL) AMINO] -1-HYDROXYETHYL} -2- (HYDROXYMETHYL) PHENOL
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
EP3833964B1 (en) 2018-08-07 2023-07-26 Norton (Waterford) Limited Application of raman spectroscopy for the manufacture of inhalation powders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122284A (en) * 1965-03-19 1968-08-07 Fisons Pharmaceuticals Ltd Inhalation device
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
CA970685A (en) 1975-07-08
NL176743C (en) 1985-06-03
JPS5046820A (en) 1975-04-25
FR2143163A2 (en) 1973-02-02
GB1381872A (en) 1975-01-29
NL7208207A (en) 1972-12-28
DK134970B (en) 1977-02-21
NL176743B (en) 1985-01-02
FR2143163B2 (en) 1975-10-31
DK134970C (en) 1977-07-18
ZA723999B (en) 1973-06-27
DE2229981B2 (en) 1980-07-03
DE2229981A1 (en) 1972-12-28
AU462722B2 (en) 1975-07-03
DE2229981C3 (en) 1981-04-02

Similar Documents

Publication Publication Date Title
AU462722B2 (en) Pharmaceutical powder composition for inhalation
CA999202A (en) Inhalator for drug powder compositions with a vortex
CA1027005A (en) Inhaler for powdered medicament
AU482733B2 (en) Pharmaceutical compositions
ZA73284B (en) Pharmaceutical powder composition containing sodium cromoglycate
CA983854A (en) Pharmaceutical composition containing nitroglycerin
IL40475A0 (en) Novel tetrazole derivatives,their preparation and pharmaceutical compositions containing them
IE35991L (en) Camphor-containing pharmaceutical composition
CA974170A (en) Pharmaceutical compositions
ZA718326B (en) Pharmaceutical composition
IL40828A0 (en) Dibenzothiepin derivatives,their manufacture and pharmaceutical compositions containing them
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL40362A0 (en) Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them
AU456733B2 (en) Pharmaceutical compositions containing benzofuran derivatives
AU461136B2 (en) Pharmaceutical composition
IL39337A0 (en) Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL39355A0 (en) Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them
IL39381A0 (en) Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them
CA864527A (en) Aerosol antiperspirant composition
IL38772A0 (en) Amino-anthracene derivatives,their manufacture and pharmaceutical compositions containing them
CA1000283A (en) Amino-indazole compounds, processes for making them and pharmaceutical compositions containing them
CA884857A (en) Pharmaceutical composition
CA885421A (en) Pharmaceutical composition
CA983859A (en) Aerosol antiperspirant composition
IL39204A0 (en) Novel aminophenylketone derivatives,processes for their preparation and pharmaceutical compositions containing the same